|
Isolated pathogens
|
Ventilator–associated pneumonia
|
Central line–associated bloodstream infection
|
Catheter–associated urinary tract infection
|
|---|
| |
(%)(n = 500)
|
(%)(n = 323)
|
(%)(n = 467)
|
|---|
|
Gram–positive cocci
|
18.0
|
30.2
|
15.9
|
|
Staphylococcus aureus
|
17.4*
|
20.4*
|
2.6
|
|
coagulase–negative staphylococcus
|
0
|
4.6
|
1.5
|
|
Enterococcus sp.
|
0
|
3.4
|
10.5*
|
|
others
|
0
|
1.5
|
0.4
|
|
Gram–positive bacilli
|
0.6
|
0.3
|
0.9
|
|
Gram–negative bacilli
|
79.6
|
44.7
|
48.2
|
|
Enterobacteriaceae
|
14.6
|
11.8
|
25.3
|
|
Escherichia Coli
|
2.4
|
2.8
|
9.9*
|
|
Klebsiella pneumoniae
|
9.4
|
5.0
|
9.2
|
|
Proteus Mirabilis
|
0.2
|
0.3
|
2.6
|
|
Serratia marcescens
|
1.0
|
3.7
|
1.7
|
|
Enterobacter sp.
|
1.6
|
0
|
1.9
|
|
non fermentative Gram negative bacilli
|
62.2
|
27.3
|
19.9
|
|
Pseudomonas aeruginosa
|
18.2*
|
5.6
|
8.8
|
|
Acinetobacter baumannii
|
23.0*
|
14.9*
|
6.9
|
|
Burkholderia cepacia
|
4.8
|
2.2
|
1.3
|
|
Stenotrophomonas maltophilia
|
12.4
|
3.1
|
1.3
|
|
others
|
3.8
|
1.5
|
1.7
|
|
other Gram–negative bacilli
|
2.8
|
5.5
|
2.9
|
|
Yeast
|
2.4
|
25.1
|
35.9
|
|
Candida Albicans
|
0.2
|
14.6*
|
4.9
|
|
non–albicans Candida spp.
|
0.2
|
6.2
|
3.4
|
|
others
|
2.0
|
4.3
|
27.6*
|
- *The first three common pathogens isolated in site–specific device–associated infection.
